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Abstract
Innate antiviral responses in bronchial epithelial cells (BECs) provide the first line of defense against respiratory viral
infection and the effectiveness of this response is critically dependent on the type I interferons (IFNs). However the
importance of the antiviral responses in BECs during influenza infection is not well understood. We profiled the innate
immune response to infection with H3N2 and H5N1 virus using Calu-3 cells and primary BECs to model proximal airway
cells. The susceptibility of BECs to influenza infection was not solely dependent on the sialic acid-bearing glycoprotein, and
antiviral responses that occurred after viral endocytosis was more important in limiting viral replication. The early antiviral
response and apoptosis correlated with the ability to limit viral replication. Both viruses reduced RIG-I associated antiviral
responses and subsequent induction of IFN-b. However it was found that there was constitutive release of IFN-b by BECs
and this was critical in inducing late antiviral signaling via type I IFN receptors, and was crucial in limiting viral infection. This
study characterizes anti-influenza virus responses in airway epithelial cells and shows that constitutive IFN-b release plays a
more important role in initiating protective late IFN-stimulated responses during human influenza infection in bronchial
epithelial cells.
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Introduction
The recent H1N1 influenza pandemic and the emergence of a
highly pathogenic avian H5N1 influenza demonstrate the danger
that this virus continues to pose, with its capability of evading our
immune response and its ability to be rapidly transmitted
throughout populations and across the globe. Much attention
has focused on the ability of the virus to evade the host adaptive
immune response through antigenic drift and antigenic shift of the
virus and the implications that this has for the development of
vaccines [1]. However, the ability of the virus to initially infect
humans and evade early innate immune responses is less well
defined, though is likely to be crucial in its ability to be transmitted
and to cause disease.
Influenza first gains entry into humans via the airway
epithelium yet little is known about this interaction and how it
may vary between strains of influenza viruses, especially those that
are more pathogenic to humans. As influenza viruses enter the
airways the haemagglutinin (HA) glycoprotein on the virus
attaches to airway epithelial cell surface glycoproteins terminating
with specific configurations of sialic acid (SA) residues. Human
influenza preferentially binds to SAa2,6Gal linkages that are
predominantly found in the upper respiratory tract, while avian
influenza viruses bind to the SAa2,3Gal residues in the lower
airway [2–5].
The airway epithelium is an important contributor to the early
innate immune response to virus infection. Type I interferons
(IFN-a/b) and the recently discovered type III IFNs (IFN-l1, -l2,
-l3) are central players in innate antiviral responses, since IFNs
initiate signalling cascades that lead to the containment of viral
spread and subsequent activation of the adaptive immune response
[6,7]. Following successful entry into the cells influenza RNA is
recognized by the intracellular RNA helicase retinoic acid-
inducible gene–I (RIG-I), which leads to the production of type
I and type III IFNs via transcription factors, interferon regulatory
factor (IRF) 3 and IRF7 [8–10]. The released type I and type III
IFNs then bind to their respective receptors IFNAR2 and IL-
28Ra/IL-10Rb on the same and/or neighbouring cells, and this
initiates the expression of over 300 IFN-stimulated genes (ISGs)
[11]. Many ISGs such as IFN-inducible protein kinase R (PKR)
signals to degrade viral RNAs and also initiate apoptosis within the
infected host cell, thereby limiting viral replication [12–16].
Infection with human influenza including H3N2 and H1N1 has
been shown to up-regulate RIG-I, type I/III IFNs and various
ISGs including PKR in dendritic cells (DCs) and airway epithelial
cells [17–21]. While these studies demonstrated that DCs are the
main producers of type I IFNs in response to infection, studies on
the ability of BECs, which is the primary infection site that
supports viral replication, to respond to influenza infection is
limited. In addition numerous studies have shown that the highly
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pathogenic avian influenza H5N1 strain has a high mortality rate
and have investigated the underlying reason for its high
pathogenicity [22–25]. Nevertheless little is known about the
kinetics and effectiveness of antiviral responses to influenza
infection in primary BECs (pBECs) and how these may differ in
response to different virus strains. We have previously shown that
BECs mount an effective innate antiviral response mediated by
RIG-I with the robust release of IFN-b, IFN-l1 and ISGs to the
low pathogenic avian influenza virus H11N9 [26]. In contrast this
response was markedly impaired to a human influenza H3N2
virus. These different responses were the result of differential
effects of viral non-structural protein 1 (NS1). Influenza viruses
encode NS1 protein to inhibit host antiviral responses, and the
NS1 from the pathogenic H3N2 strain more effectively inhibited
RIG-I mediated signalling and the inductions of type I and III
IFNs, whereas the NS1 from the H11N9 strain did not. Several
studies have also shown that the NS1 protein of highly pathogenic
avian H5N1 virus is also very potent in the host antiviral
suppression [27–29]. Intriguingly, we also observed that IFN-b
protein release occurred even in the absence of influenza infection
[26]. If and how this constitutive release of IFN-b contributes to
antiviral responses to influenza infection remains unknown.
In this study we assessed the antiviral responses of human BECs
to human influenza, H3N2, and highly pathogenic avian
influenza, H5N1, using a proximal airway epithelial cell line,
Calu-3 cells, and pBECs obtained by bronchoscopy from healthy
volunteers. We have defined the critical role of the constitutive
IFN-b release during influenza infection, which is required to
initiate the early induction of ISG expression and infected cell
apoptosis. These factors are critical in the ability of BECs to limit
influenza replication, even in the face of effective inhibition of
inducible type I IFN responses by the influenza NS1 protein.
Results
Influenza viral replication in BECs is independent of sialic
acid residue expression
We first compared the replication of H3N2 in an immortalized
cell line (Calu-3 cells) and pBECs (Figure 1). A dose- and time-
response of H3N2 was determined on both Calu-3 cells and
pBECs with and without trypsin treatment, and MOI of 5 was
shown to elicit appropriate induction of immune responses without
causing significant cytopathic effect. Thus an MOI of 5 was used
in all experiments. In these dose- and time-response studies trypsin
treatment on Calu-3 cells and pBECs was found not to affect
H3N2 replication rate and antiviral responses (data not shown)
and was not included in subsequent experiments. After infection
we found that H3N2 replicated to a significantly higher viral titre
in Calu-3 cells compared to pBECs (Figure 1A). As influenza
viruses bind to SAa2,6Gal residues to facilitate their entry into
cells, we next assessed if these residues were more highly expressed
in Calu-3 cells (Figure 1B). Surprisingly the opposite was the case,
and SAa2,6Gal residues were expressed to a significantly lower
level on Calu-3 cells compared to pBECs. This suggested that viral
binding and entry into airway epithelial cells is not solely
dependent on the level of SAa2,6Gal residues, and that post-
endocytotic events are more important in limiting influenza
infection.
Antiviral responses in BECs are reduced during influenza
infection
We then compared antiviral responses of Calu-3 cells and
pBECs to H3N2 infection and Poly I:C, by assessing the induction
of RIG-I, PKR and IFN-b genes and proteins (Figures 2, S1 and
S2). H3N2 infection and Poly I:C stimulation resulted in
significant inductions of antiviral genes in Calu-3 cells (Figure
S1) and pBECs (Figure S2), compared to the media control. UV-
inactivated virus was no different to the media control (data not
shown).
Infection of Calu-3 cells resulted in an early induction of RIG-I
mRNA at 6 h with a progressive rise (25 fold) to 72 h (Figure S1A).
This was followed by increases in IFN-b (24–72 h) and PKR (48–
72 h) mRNAs later in the time-course (Figure S1B–C). Infection
resulted in the significant protein production of RIG-I (Figure 2A)
and PKR (Figure 2C) but not IFN-b after 48 h (Figure 2B).
Notably there was constitutive IFN-b protein present in Calu-3
cells cultured with media alone (Figure 2B).
In pBECs, infection induced an early and sustained induction
of RIG-I mRNA (Figure S2A), this was again followed by a
Figure 1. H3N2 influenza virus replication, SAa2,6Gal and SAa2,3Gal linked glycoprotein levels on Calu-3 cells and pBECs. Calu-3
cells and pBECs were infected with H3N2 influenza virus at an MOI of 5. (A) Viral replication was measured by plaque assay after 48 h. (B) The level of
surface expression of SAa2,6Gal linked glycoproteins was measured by flow cytometry. Results were derived from three independent experiments
and are presented as mean 6 standard error of the mean (SEM).
doi:10.1371/journal.pone.0032947.g001
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significant induction of IFN-b and PKR mRNA by 24 h (Figure
S2B–C). Infection again induced significant protein production
of RIG-I and PKR but not IFN-b after 48 h (Figure 2A–C).
There was also constitutive IFN-b protein present in pBECs
cultured with media alone (Figure 2B). Treatment of both cell
types with Poly I:C resulted in the significant gene expression
and protein production of all antiviral responses (Figures 2, S1
and S2).
These results indicate that during H3N2 infection of both cell
types there was early RIG-I induction and later PKR production.
In contrast although there was significant gene induction, IFN-b
protein release was not enhanced.
RIG-I induction does not affect influenza infection
We then assessed whether RIG-I induction was important in the
antiviral responses of pBECs against influenza infection. RIG-I
was suppressed in pBECs using siRNA treatment before and
during H3N2 infection or Poly I:C exposure and the effects on
antiviral responses were assessed (Figure 3).
RIG-I silencing resulted in over 60% knockdown in RIG-I
mRNA levels (Figure 3A). The use of a siRNA negative control
was also used to confirm that knockdown was RIG-I-specific. In
contrast to when RIG-I was present, when RIG-I was silenced
H3N2 did not induce RIG-I mRNA and protein, and Poly I:C-
induced RIG-I mRNA and protein production was attenuated
compared to RIG-I-intact cells (Figure 3A and 3B).
When RIG-I was present IFN-b protein was significantly
induced by Poly I:C but not by H3N2 infection compared to
media only control (Figure 3C). When RIG-I was silenced IFN-b
protein was decreased in RIG-I-silenced media control cells,
however IFN-b protein was not reduced in H3N2 infected RIG-I
silenced cells, and was significantly higher than that in RIG-I-
Figure 2. Type I IFN signalling and responses to H3N2 infection in Calu-3 cells and pBECs. Calu-3 cells and pBECs were either infected
with H3N2 influenza virus or stimulated with Poly I:C, and RIG-I, IFN-b, and PKR protein production was measured by western blotting. (A) RIG-I in
whole cell lysates compared to media control. (B) IFN-b in culture supernatants at 48 h compared to media control. (C) PKR protein in cell lysates
compared to media control. Western blots of Calu-3 cells and pBECs were performed separately. Results were derived from three independent
experiments and are presented as mean 6 standard error of the mean (SEM). * - **** indicates significant induction from media control. 1 and 11
indicates a significant reduction compared to media control.
doi:10.1371/journal.pone.0032947.g002
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Figure 3. Role of RIG-I in IFN-b response to H3N2 influenza virus infection in pBECs. RIG-I siRNA was added to pBECs to silence RIG-I mRNA
24 hr before H3N2 influenza virus infection. Cells were then infected with H3N2 or treated with Poly I:C. (A) RIG-I mRNA was measured by RT-qPCR at
24 h. (B) RIG-I, (C) IFN-b and PKR protein was measured at 48 h by western blotting. siRNA negative control was also used to confirm RIG-I siRNA used
was RIG-I-specific, and did not affect IFN-b and PKR protein induction (data not shown). IFN-b and PKR western blot was rearranged from the same
blot. (D) Viral replication was measured by plaque assay after 48 h. Results were derived from three independent experiments and are presented as
mean 6 standard error of the mean (SEM). * - **** indicates significant induction from media control. + and ++ indicates significant induction from
siRIG-I-treated media only control cells. 1 indicates a significant reduction compared to media control.
doi:10.1371/journal.pone.0032947.g003
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silenced media controls. RIG-I knockdown partially reduced Poly
I:C-induced IFN-b protein production, which was still increased
compared to RIG-I-silenced media controls (Figure 3C). Criti-
cally the suppression of RIG-I also did not alter the replication
efficiency of H3N2 influenza (Figure 3D).
Collectively, these results suggest that RIG-I is important in the
induction of IFN-b expression, however it is not the only factor
involved in the IFN-b response. Furthermore, low-level consti-
tutive IFN-b may play a more important role in controlling
H3N2 influenza infection than RIG-I-mediated inducible IFN-b
response.
Constitutive intracellular IFN-b is present and can be
released during host protein synthesis inhibition
We then further assessed the contribution of constitutive IFN-b
protein production to antiviral responses against influenza
infection. This was achieved by examining the effects of
suppressing IFN-b production before infection (Figure 4).
Calu-3 cells and pBECs were pre-treated with cycloheximide to
inhibit protein synthesis prior to infection. As expected GAPDH
was not detected after treatment with cycloheximide, indicating
successful inhibition of protein synthesis (Figure 4A). Cyclohexi-
mide also inhibited H3N2 replication by preventing host cell
Figure 4. H3N2 replication and IFN-b release following protein synthesis inhibition with cycloheximide in Calu-3 cells and pBECs.
Cycloheximide was added to Calu-3 cells and pBECs to inhibit protein synthesis 30 min before H3N2 infection or Poly I:C treatment. (A) GAPDH was
measured at 6 h after H3N2 infection and Poly I:C stimulation by western blotting. (B) Viral replication was measured by plaque assay after 48 h. (C)
IFN-b release was measured by western blotting at 48 h. Western blots of Calu-3 cells and pBECs were performed separately. Results were derived
from three independent experiments and are presented as mean 6 standard error of the mean (SEM). * indicates significant induction from media
control. 1 indicates a significant reduction compared to media control.
doi:10.1371/journal.pone.0032947.g004
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protein synthesis as expected (Figure 4B). Unexpectedly, however,
there was an enhanced release of IFN-b protein in response to
H3N2 infection, Poly I:C and media compared to that without
cycloheximide treatment (Figure 4C). This suggested that the IFN-
b protein released was pre-formed and stored inside the cell, and
infection was triggering the release of pre-formed IFN-b.
We then assessed if pre-formed IFN-b was present intracellu-
larly by staining pBECs 6 h after H3N2 infection or Poly I:C
stimulation with and without cycloheximide treatment with goat-
raised anti-IFN-b primary antibody and secondary anti-goat
IgG:FITC antibody (Figure 5). The nuclei were stained with
DAPI, and cells were viewed using confocal microscopy. Goat
raised anti-GFP primary antibody with anti-goat IgG:FITC
secondary antibody, and anti-goat IgG:FITC antibody alone
(isotype control) were used as negative controls to confirm the
specificity of anti-IFN-b antibody. IFN-b protein (FITC, green)
was detectable intracellularly after H3N2 infection, Poly I:C
stimulation and in un-treated media controls in the absence of
cycloheximide. Poly I:C stimulation resulted in an elevated level of
IFN-b protein inside pBECs compared to H3N2 and media.
Cycloheximide pre-treatment in each of these conditions resulted
in the inability to detect intracellular IFN-b in pBECs, suggesting
that all IFN-b had been released into the supernatants as observed
in Figure 4C.
The presence of intracellular IFN-b was also confirmed in
differentiated, uninfected pBECs (Figure S3). Differentiated
pBECs were stained with H&E stain for nucleus and alcian blue
for mucus to indicate successful differentiation at air-liquid
interface (Figure S3A). Differentiated pBECs showed similar sialic
acid residue expression (Figure S3B) and the presence of
intracellular IFN-b (Figure S3C) as that observed in non-
differentiated cells.
Collectively these results provide further evidence for the
presence of pre-formed constitutive IFN-b protein in pBECs,
which can be released into supernatants upon host protein
inhibition.
Constitutive IFN-b release plays a critical role in
suppressing influenza infection
To determine the functional role of constitutive IFN-b during
influenza infection, we assessed if enhanced IFN-b release was
associated with increased antiviral activity in limiting influenza
plaque formation. Supernatants of cycloheximide-treated (CHX-
M) or untreated (M) Calu-3 cells and pBECs media control cells
were mixed with H3N2 virus (16105 pfu/ml) and standard plaque
assays were performed on MDCK cells. CHX-M dramatically
suppressed H3N2 plaque formation compared to a partial but
significant decrease induced by M (Figure 6A). In contrast, neither
supernatant reduced viral titres when the IFN-b receptor IFNAR2
was blocked with neutralizing antibody (IFNAR2 nAb) on MDCK
cells in the plaque assay. This demonstrates that the increased
Figure 5. Intracellular release of IFN-b during H3N2 influenza virus infection in the presence of cycloheximide in Calu-3 cells and
pBECs. Calu-3 cells and pBECs were pre-treated with cycloheximide and infected with H3N2 or treated with Poly I:C on coverslips and mounted on
microscopic slides. The cells were then stained with goat raised anti-IFN-b antibody with secondary anti-goat IgG:FITC antibody. Goat raised anti-GFP
antibody with anti-goat IgG:FITC and anti-goat IgG:FITC alone was used as negative control. The presence of IFN-b (FITC, green) was assessed by
confocal microscopy. Nuclei were stained with DAPI. Goat raised anti-GFP antibody with anti-goat IgG:FITC, and IgG:FITC alone showed no non-
specific binding in pBECs. Results were derived from three independent experiments.
doi:10.1371/journal.pone.0032947.g005
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IFN-b protein in the cycloheximide treated cells effectively
inhibited viral plaque formation.
Apoptosis has previously been known to limit viral replication
[30,31]. Thus we then assessed the role of IFN-b in host cell
apoptosis during influenza infection (Figure 6B). Cycloheximide
treatment alone caused a significant induction of apoptosis that
progressed with time, especially in pBECs (data not shown). This
effect was accelerated in pBECs when also infected with H3N2 or
treated with Poly I:C (Figure 6B). In Calu-3 cells where viral
replication occurred more effectively (Figure 1), there was
relatively less apoptosis, though it still increased compared to
control cells (Figure 6B).
To further confirm the role of the constitutive IFN-b in
influenza infection, we blocked the IFNAR2 during H3N2
infection with a neutralizing antibody (Figure 7). Blocking the
IFN-b receptor substantially reduced IFN-b protein levels
following infection, Poly I:C stimulation and in the media control
(Figure 7A). The decrease in IFN-b was accompanied by reduced
apoptosis during infection (Figure 7B). This led to significant
increases in H3N2 titres compared to un-treated cells (Figure 7C).
Collectively these results suggest that while IFN-b production
was inhibited by H3N2, the production and activity of constitutive
IFN-b together with viral recognition was sufficient to trigger host
cell apoptosis and suppress viral replication.
Apoptosis is critical in limiting H3N2 replication
Calu-3 cells and pBECs had similar magnitudes of antiviral
responses to infection, but supported very different levels of H3N2
replication. Therefore, we then further investigated the mecha-
nisms of differential replication by measuring apoptosis levels
during infection in Calu-3 cells and pBECs (Figure 8).
Increased viral titres in infected Calu-3 cells (Figure 1A) were
accompanied by reduced levels of apoptosis compared to pBECs
(Figure 8A). To determine if apoptosis directly impaired viral
replication, the pan-caspase inhibitor z-DEVD-Fmk was used to
inhibit apoptosis during infection. Treatment with the inhibitor
reduced apoptosis during H3N2 infection (Figure 8B) and
significantly increased viral replication in both cell types
(Figure 8C), though IFN-b protein levels remained unchanged
(Figure 8D).
This indicates that host cell apoptosis is crucial in limiting
influenza viral replication, especially in pBECs, and is induced by
the combination of infection and constitutive IFN-b release.
Figure 6. Anti-H3N2 influenza virus activity of constitutive IFN-b in limiting H3N2 plaque formation. (A) Supernatants from
cycloheximide-treated un-infected Calu-3 cells and pBECs (CHX-M) was mixed with H3N2 influenza virus (16105 pfu/ml), and standard plaque assay
was performed on MDCK cells with and without IFNAR2 neutralization. IFNAR2 nAb was added to MDCK cells 1 h before plaque assay was performed.
(B) Apoptosis was measured by staining the cells with AxV and 7-AAD and analysis using flow cytometry 6 h after H3N2 and Poly I:C treatment.
Apoptotic cells were AxV positive and 7-AAD negative. Results were derived from three independent experiments and are presented as mean 6
standard error of the mean (SEM). * - **** indicates significant induction from media control. 1 and 11 indicates significant reduction compared to
media control.
doi:10.1371/journal.pone.0032947.g006
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Figure 7. H3N2 influenza virus replication, IFN-b production and apoptosis in IFNAR2 neutralized Calu-3 cells and pBECs. IFNAR2
was blocked with IFNAR2 neutralizing antibody in Calu-3 cells and pBECs before H3N2 influenza virus infection or treatment with Poly I:C. (A) IFN-b
production was assessed at 48 h after H3N2 and Poly I:C treatment by western blotting. (B) Apoptosis was measured at 6 h using flow cytometry. (C)
Viral replication was measured by plaque assay after 48 h. Western blots of Calu-3 cells and pBECs were performed separately. Results were derived
from three independent experiments and are presented as mean 6 standard error of the mean (SEM). * - **** indicates significant induction from
media control. 1 indicates a significant reduction compared to media control.
doi:10.1371/journal.pone.0032947.g007
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H5N1 replicated to high titre with complete abolishment
of antiviral responses and apoptosis in infected BECs
While H3N2 effectively inhibited inducible IFN-b to facilitate
virus replication, replication was still limited through the effect of
constitutive IFN-b release and host cell apoptosis. We then
investigated whether the highly pathogenic H5N1 strain might
have enhanced virulence through more potent inhibition of these
host defences.
H5N1 infection of Calu-3 cells was initially performed at an
MOI of 5, however this led to a complete destruction of the cell
monolayer. Subsequently an MOI of 0.005 was found to be
optimal in cell viability as this dose led to minimal cytopathic
Figure 8. Effect of apoptosis on H3N2 replication in Calu-3 cells and pBECs. Calu-3 cells and pBECs were infected with H3N2 influenza virus
or treated with Poly I:C. (A) Apoptosis was measured at 6 h after H3N2 and Poly I:C treatment by using flow cytometry. (B) z-DEVD-Fmk was
administered 3 h before H3N2 and Poly I:C stimulation to similar cultures to inhibit apoptosis, and apoptosis was measured at 6 h. (C) Viral replication
was measured by plaque assay after 48 h. (D) IFN-b production was assessed at 48 h after H3N2 and Poly I:C treatment by western blotting. Western
blots of Calu-3 cells and pBECs were performed separately. Results were derived from three independent experiments and are presented as mean 6
standard error of the mean (SEM). * and ** indicates significant induction from media control.
doi:10.1371/journal.pone.0032947.g008
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effect. Even at this much reduced dose H5N1 replicated more to a
higher titre in both cell types (Figure 9A) compared to H3N2
infection (Figure 1A). This was despite the limited expression of
SAa2,3Gal residues that are the preferred receptors for avian
influenza (Figure 1B). H5N1 titre was significantly higher in
pBECs than in Calu-3 cells (Figure 9A), in contrast to that
observed with H3N2 infection (Figure 1A). Also in contrast to
H3N2, H5N1 infection resulted in no induction of RIG-I, PKR,
and IFN-b mRNA (data not shown) or protein (Figure 9B). As a
result of constraints in working with H5N1 it was not possible to
measure apoptosis using flow cytometry, therefore apoptosis was
measured by assessing Bax protein expression (Figure 9C). In
agreement with results using AxV/7AAD staining (Figure 8A),
Bax was only induced above baseline levels in pBECs but not
Calu-3 cells during H3N2 infection (Figure 9C). H5N1 infection
did not up-regulate Bax expression in either cell type (Figure 9C).
Collectively these results indicate that H5N1 infection effectively
inhibited both the inducible IFN-b response and the action of
constitutive IFN-b on inducing apoptosis that enabled high levels
of viral replication.
Discussion
Here we demonstrate that antiviral response to pathogenic
human and avian influenza infection in airway epithelial cells is
critically dependent on constitutive IFN-b release and IFN-b
signalling rather than the abundance of sialic acid residues or
RIG-I-mediated pathways as previously thought. H3N2 infection
was able to limit inducible IFN-b induction in BECs, however the
constitutive release of IFN-b provided an effective innate immune
response that limited viral replication in the infected BECs. In
pBECs there was an early induction of RIG-I and a greater
proportion of infected cells underwent apoptosis that was
associated with reduced viral replication. However the RIG-I
responses was not required to suppress viral replication. Impor-
tantly, the constitutive release of IFN-b played a critical role in
triggering apoptosis and limiting viral replication in infected BECs.
Furthermore, blocking the type I IFN receptor or apoptosis
enhanced viral replication. In contrast infection of BECs with
H5N1 resulted in inhibition of both inducible and constitutive
IFN-b release, and impaired apoptosis that led to highly efficient
Figure 9. H5N1 influenza virus replication, type I IFN signalling and responses, and apoptosis in Calu-3 cells and pBECs. Calu-3 cells
and pBECs were infected with H5N1 influenza virus at MOI of 0.005. (A) Viral replication was measured by plaque assay after 48 h. (B) RIG-I and IFN-b,
and (C) Bax were assessed at 6 h after H3N2 and Poly I:C treatment by western blotting. Western blots of Calu-3 cells and pBECs were performed
separately. Results were derived from three independent experiments and are presented as mean 6 standard error of the mean (SEM). * and **
indicates significant induction from media control. 1 indicates a significant reduction compared to media control.
doi:10.1371/journal.pone.0032947.g009
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viral replication, demonstrating the important role the innate
immune response in determining early antiviral responses.
Calu-3 cells and pBECs are well characterized and accepted as
a model of the proximal airway epithelium. Calu-3 cells and
pBECs have been used to assess immune responses to other viral
infection such as rhinovirus, by our group and others [32–35]. We
have also previously characterized the response of Calu-3 cells to
influenza infection, which was also confirmed in pBECs in our
previous study [36]. However this study demonstrated important
differences in antiviral responses to infection and susceptibility to
influenza infection. Lower levels of SAa2,6Gal linked glycoprotein
expression were observed on Calu-3 cells compared to pBECs,
however H3N2 replication was greater in Calu-3 cells. In addition,
avian H5N1 strain, although used at a significantly lower dose,
replicated to a even higher extent in Calu-3 cells and pBECs,
despite of the low levels of SAa2,3Gal residues. These observations
are in accordance with our previous work that demonstrated
similar HA levels immediately after human and avian influenza
viral infection in Calu-3 cells and pBECs irrespective of these sialic
acid residues [26]. These sialic acid-bearing glycoproteins
therefore may only have a minor role in susceptibility, and that
post-endocytosis antiviral responses are more important determi-
nants of influenza replication.
Antiviral responses are critically important in suppressing viral
spread early in infection. In our study pBECs were more resistant
to H3N2 infection due to higher levels of apoptosis after infection,
which led to reduced viral replication. In contrast Calu-3 cells did
not readily undergo apoptosis, which resulted in more efficient
replication. The reason for this difference in apoptosis is probably
due to the nature of immortalized cell lines, and results from
pBECs provide a better insight into the natural human host cell
response to influenza infection.
Primary BECs showed early and late increases in RIG-I
expression after H3N2 infection. While numerous studies
demonstrated the importance of RIG-I in influenza RNA
recognition and subsequent signal transduction to induce IFNs
[17,37–42], in this study suppressing RIG-I affected neither IFN-b
protein expression nor H3N2 replication efficiency in pBECs. This
suggests that while RIG-I is critical in viral RNA recognition,
RIG-I-signalling may not be important in influenza infection as its
signalling pathway is interfered by the influenza NS1 protein
[36,43], and other factors are critical in controlling viral
replication. The lack of IFN-b induction after H3N2 infection is
known to result from the suppression by the influenza NS1
protein. We have previously shown that the NS1 protein of the
H3N2 strain was more potent in inhibiting the antiviral type I IFN
response than that of a low pathogenic H11N9 avian influenza
virus [26]. The host binding targets of NS1 include IRF3
phosphorylation [44], TRIM25 [45], NK-kB [46–48], and cellular
mRNA translation processes [49]. This results in impaired innate
immune responses in infected host cells.
Despite this inhibition of inducible type I IFN in BECs, we still
observed a selective induction of RIG-I and PKR protein late in
H3N2 infection, and the constitutive release of IFN-b played a
pivotal role in this late antiviral signalling. Cycloheximide was
used as a general inhibitor of host protein synthesis to determine if
the IFN-b was induced in response to infection or was pre-existing.
Treatment with cycloheximide resulted in complete loss of
GAPDH protein. GAPDH has been shown to be degraded in
the presence of oxidative stress in eukaryotic cells [50], and
cycloheximide has significant toxic side effect that enhances
intracellular oxidative stress, that together with the inhibition of
host protein synthesis resulted in this loss. Cycloheximide also
resulted in the release of the intracellular pool of pre-formed IFN-
b into infection supernatants, which was important in up-
regulating apoptosis and limit viral replication, before it had any
effect on cell viability. The constitutive IFN-b was functionally
active as the enhanced IFN-b in cycloheximide treated cells
effectively limited H3N2 replication, and inhibition of IFNAR2
markedly reduced IFN-b-induced apoptosis and increased viral
replication. The antiviral effect of type I IFN in reducing viral
replication is well established [51], and we have previously shown
that exogenous IFN-b was able to reduce viral replication of
H3N2 and a low pathogenic avian H11N9 strain [36]. We cannot
rule out that type III IFNs are also involved in limiting influenza
viral replication. Type III IFNs are induced and functions in a
similar fashion to type I IFNs that amplify antiviral ISGs, and
while both IFN-b and IFN-l1 were found to be critical in reducing
viral replication, we have also shown that IFN-l1 was not induced
upon H3N2 infection [36]. Influenza, as well as many other RNA
viruses such as herpes simplex virus are known to preferentially
and effectively inhibit host cell protein synthesis and promote viral
protein synthesis and replication [52]. Our results suggest that the
inhibition of protein synthesis by the virus may acts as a trigger for
the release of pre-formed IFN-b and apoptosis in the infected host
cells and this release appeared to be RIG-I- and apoptosis-
independent. Cycloheximide has been shown to induce apoptosis
[53,54], and while elevated apoptosis level with cycloheximide
treatment correlated with increased IFN-b release, it is unlikely
that the constitutive IFN-b release was dependent on apoptosis.
The characteristics of apoptosis including cell shrinkage with
maintained membrane integrity without leakage of internal
materials suggest the constitutive IFN-b release involves novel
signalling pathways. A similar response has also been observed in
cells infected with Newcastle Disease virus (NDV). Cells treated
with cycloheximide during NDV infection released greater
amounts of IFN-b, which was thought to occur through enhanced
stability of IFN mRNA [55]. This, however, does not explain the
constitutive release of IFN-b protein when host protein synthesis
was blocked at the protein translational level by cycloheximide.
While the exact mechanism by which IFN-b protein is released
when protein synthesis is blocked is unclear, this constitutively
released IFN-b is functionally more important in limiting viral
replication via IFN-b-IFNAR2 signalling than the initial RIG-I
initiated signalling.
The constitutive release of IFN-b demonstrated here has been
reported previously in vitro and in vivo [56–60], and was
hypothesized to play a role in the priming and enhancement of
IFN response, as proposed in a ‘‘revving-up model’’ [59,61]. A
constitutive weak signal induced by IFN-b-IFNAR2 signalling
allows epithelial cells to elicit a more robust response toward viral
infection, while in the absence of this signal epithelial cells become
hypo-responsive to this stimulus. Despite the critical role of
constitutive IFN-b in H3N2 infection, H5N1 inhibited all antiviral
signalling more effectively in infected cells, including signalling
induced by constitutive IFN-b. This may have occurred as a result
of the potent suppressive properties of the H5N1 NS1 protein
[23,25,27–29,62–65], leading to highly efficient viral replication in
these cells.
Collectively our results demonstrate that the constitutive type I
IFN response of infected BECs is important in determining the
level of influenza replication. Influenza viral replication is not
dependent on the sialic acid residue-bearing glycoproteins, and the
antiviral responses have an important role in limiting virus
replication, particularly the effect of constitutive release of IFN-b
during infection. In the early phase of infection epithelial cells have
limited ability to produce IFN-b due to effective influenza NS1
protein. However constitutive IFN-b response counteracts some of
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the suppressive effects of the influenza virus, via IFNAR2
signalling to induce expression of ISGs including RIG-I and
PKR. These ISGs are important in establishing an antiviral state
in BECs as they are the effector antiviral proteins that inhibit viral
mRNA translation, inducing apoptosis and amplify the entire IFN
response.
Materials and Methods
Influenza virus
Human influenza A/Wellington/43/2006 (H3N2) strain and
A/Vietnam/1203/04 (H5N1) was obtained from the WHO
Collaborating Centre for Reference and Research on Influenza
(Vic, Australia). Influenza viruses were propagated and virus titres
determined by plaque assays on Madin-Darby canine kidney
(MDCK) cells (American Type Culture Collection (ATCC), USA)
[66]. Ultra-violet (UV) inactivation of live viruses was achieved by
placing live viruses directly under UV lamp (254 nm) for 4 h.
Successful inactivation was confirmed by plaque assays. All work
with H5N1 was performed in the level 4 containment facility at
The Commonwealth Scientific and Industrial Research Organi-
zation (CSIRO) - Australian Animal Health laboratory, Geelong,
Victoria, Australia.
Cell culture and viral infection
Calu-3 and MDCK cells (ATCC) were maintained in minimum
essential media supplemented with 10% fetal bovine serum and
Dulbecco’s modified Eagle’s media with 5% fetal bovine serum,
respectively [26]. Human pBECs were obtained from healthy
individuals by endobronchial brushing during fibre-optic bron-
choscopy [67]. Subjects had no history of smoking or lung disease
and had normal lung function. All subjects gave written consent.
pBEC were cultured as described [26,35]. For differentiation of
pBECs, cells were grown on transwells (Corning) at air-liquid
interface, with basolateral media changed every second day at
37uC/5% CO2 [68].
H3N2 and H5N1 were diluted in the appropriate serum free
media and added to cells at multiplicity of infection (MOI) of 5
and of 0.005, respectively. After 1 h of incubation, the inocula
were removed and replaced with serum-free media. Cells were
treated with exogenous polyinosinic:polycytidylic acid (Poly I:C,
100 mg/ml, Sigma-Aldrich), a known agonist of RIG-I and IFN
responses, as a positive control [36,69]. Cycloheximide (100 ug/
ml, Sigma-Aldrich) was used to inhibit protein synthesis by pre-
treatment of cells (30 min, 37uC, 5% CO2) and was added to
media after virus inoculation. Caspases inhibitor Z-DEVD-fmk
(Calbiochem, USA) of 50 mM was used to pre-treat the cells for
3 h before infection and was added after 1 hr virus inoculation. In
experiments involving the blockade of IFNAR2, cells were
incubated with 1 mg/ml of mouse monoclonal neutralizing
antibody to IFNAR2 (CD118, PBL Laboratories) for 1 h prior
to virus inoculation.
Antiviral assay
Supernatants from cycloheximide treated and untreated
uninfected media control cells were standardized to 100 mg and
added to H3N2 virus at 16105 plaque forming unit (pfu)/ml and
standard plaque assay was performed on MDCK cells [66].
RNA interference
siRNA to RIG-I (Applied Biosystems) was complexed with
siPORT NeoFX transfection agent (Applied Biosystem) and
diluted to 10 nM with OPTI-MEM-I (Invitrogen). The siRNA
complex was added to the cells and induced .60% knockdown
after 24 hr. H3N2 infection was performed at this point.
Flow cytometry
FITC conjugated Sambucus niger agglutinin (SNA) and Maackia
amurensis (MAA) II lectins (Vector Laboratories) were used to
identify SAa2,6Gal and SAa2,3Gal residues, respectively. BECs
were stained with FITC-SNA at 10 mg/ml and incubated at 4uC
for 1 h. The cells were then analysed using flow cytometry
(FACSCanto II, Becton Dickinson) and results were expressed as
median fluorescence intensity [26].
Apoptosis
Apoptosis was measured using PE Annexin V Apoptosis
Detection kit I (Becton Dickinson) according to manufacturer’s
instruction. Cells were harvested and stained with annexin V-PE
(AxV) stain and vital dye 7-amino-actinomycin (7-AAD) and then
analyzed using a FACSCanto II (Becton Dickinson) and
FACSDiva software. Apoptotic cells were stained AxV positive/
7-AAD negative and expressed as percentage of total analyzed
cells.
RT-qPCR
RNA was extracted from infected Calu-3 cells using RNeasy
Mini Kits (Qiagen) according to the manufacturer’s instructions.
RNA (1 mg) was reverse transcribed to cDNA and was used for
RT-qPCR assays (Applied Biosystem). Ribosomal RNA (18S) was
used as the reference gene. The cycle threshold (Ct) value obtained
was normalized to that of the 18S gene, and expressed as fold
induction over the media control.
Immunoblotting
Calu-3 cells and pBECs were lysed in RIPA buffer, and all
proteins were standardized to 10 mg and were resolved by SDS-
PAGE, and transferred onto nitrocellulose membranes for
detection of IFN-b in supernatants, RIG-I, PKR, and Bax in cell
lysates. GAPDH was detected as a loading control for proteins in
cell lysates. Protein estimation was determined by densitometry
and the values were expressed as protein/GAPDH ratio and
presented as fold induction from media control. As there is no
loading control available for secreted proteins, densitometric
values for IFN-b was presented as fold induction from media
control.
Immunofluorescence and confocal microscopy
Calu-3 cells and pBECs were fixed in 4% paraformaldehyde/
4% sucrose, permeabilized with 0.5% Triton X-100/PBS, and
subjected to confocal microscopy. Cells were stained with goat
raised anti-human IFN-b primary antibody (1 mg/ml, Abcam) and
anti-goat secondary IgG:FITC (5 ng/ml, Abcam), and counter-
stained and mounted with ProLong Gold antifade reagent with
DAPI (Invitrogen). Goat raised anti-green fluorescent protein
(GFP) primary antibody (1 mg/ml, Abcam) with secondary anti-
goat IgG:FITC (5 ng/ml), and anti-goat IgG:FITC (5 ng/ml)
alone were used as negative staining controls. The differentiated
pBECs was sectioned, and stained with alcian blue for mucus and
H&E stain for the nucleus to confirm cell morphology. Sialic acid
residues (FITC conjugated SNA and APC conjugated MAA II
lectins, Vector Laboratories) and the presence of intracellular IFN-
b was also stained in differentiated pBECs. The cells were viewed
with a confocal laser scanning microscope (Olympus FluoView
1000, Olympus). Images were digitally recorded and analysed by
FV10-ASW (Olympus).
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Antibodies
All antibodies used in this study are commercially available and
have been validated by the source companies.
Data analysis
Data were expressed as mean 6 standard error of mean (SEM).
All data presented in the results were normally distributed, and
statistical analysis was performed using student’s two-tailed t test. A
p-value of ,0.05 was considered significant. The study was
approved by The University of Newcastle Human Research Ethics
Committee.
Supporting Information
Figure S1 Induction of type I IFN gene expression in
response to H3N2 influenza virus infection in Calu-3
cells. Calu-3 cells were infected with H3N2 influenza virus or
treated with Poly I:C. (A) RIG-I, (B) IFN-b and (C) PKR mRNA
was measured by RT-qPCR at 6, 12, 24, 48 and 72 h after
infection. UV-inactivated virus was no different to the media
control (data not shown). Results were derived from three
independent experiments and are presented as mean 6 standard
error of the mean (SEM).
(TIFF)
Figure S2 Induction of type I IFN gene expression in
response to H3N2 influenza virus infection in pBECs.
pBECs were infected with H3N2 influenza virus or treated with
Poly I:C. (A) RIG-I, (B) IFN-b and (C) PKR mRNA was measured
by RT-qPCR at 6, 12, 24, 48 and 72 h after infection. Results
were derived from three independent experiments and are
presented as mean 6 standard error of the mean (SEM).
(TIFF)
Figure S3 Cell morphology, SAa2,6Gal and SAa2,3Gal
residue expression, and intracellular IFN-b in differen-
tiated pBECs. pBECs were cultured at an air-liquid interface.
(A) The differentiated phenotype was assessed by H&E staining for
nuclei and alcian blue staining for mucus. (B) SAa2,6Gal and
SAa2,3Gal residues were stained with FITC-SNA and APC-
MAL-II, respectively, and assessed using confocal microscopy. (C)
IFN-b was also stained with goat raised anti-IFN-b with anti-boat
IgG:FITC and assessed with confocal microscopy. Results were
derived from three independent experiments.
(TIFF)
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